Danaher Co. (NYSE:DHR) Shares Purchased by Mosaic Family Wealth Partners LLC

Mosaic Family Wealth Partners LLC grew its stake in shares of Danaher Co. (NYSE:DHR) by 75.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,087 shares of the conglomerate’s stock after purchasing an additional 900 shares during the quarter. Mosaic Family Wealth Partners LLC’s holdings in Danaher were worth $521,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Cary Street Partners Investment Advisory LLC grew its holdings in shares of Danaher by 20.2% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 9,128 shares of the conglomerate’s stock valued at $2,112,000 after purchasing an additional 1,533 shares during the last quarter. Cercano Management LLC grew its holdings in shares of Danaher by 11.4% during the fourth quarter. Cercano Management LLC now owns 202,569 shares of the conglomerate’s stock valued at $46,862,000 after purchasing an additional 20,715 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Danaher by 48.1% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 296,996 shares of the conglomerate’s stock valued at $68,707,000 after purchasing an additional 96,395 shares during the last quarter. Donaldson Capital Management LLC grew its holdings in shares of Danaher by 5.8% during the first quarter. Donaldson Capital Management LLC now owns 1,469 shares of the conglomerate’s stock valued at $367,000 after purchasing an additional 80 shares during the last quarter. Finally, Caden Capital Partners LP grew its holdings in Danaher by 12.4% in the 4th quarter. Caden Capital Partners LP now owns 139,068 shares of the conglomerate’s stock worth $32,172,000 after buying an additional 15,313 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Insider Activity

In other news, CFO Matthew Mcgrew sold 16,172 shares of the stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $279.84, for a total value of $4,525,572.48. Following the completion of the sale, the chief financial officer now owns 29,407 shares in the company, valued at $8,229,254.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CFO Matthew Mcgrew sold 16,172 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $279.84, for a total value of $4,525,572.48. Following the transaction, the chief financial officer now directly owns 29,407 shares of the company’s stock, valued at $8,229,254.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Rainer Blair sold 9,005 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the completion of the transaction, the chief executive officer now directly owns 106,990 shares in the company, valued at $28,352,350. The disclosure for this sale can be found here. Insiders sold 113,174 shares of company stock worth $29,775,644 over the last quarter. Corporate insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR traded down $4.01 on Friday, reaching $276.75. 3,108,808 shares of the company traded hands, compared to its average volume of 3,183,765. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $281.70. The company’s 50 day moving average is $256.29 and its 200-day moving average is $250.94. The stock has a market capitalization of $199.87 billion, a PE ratio of 46.91, a P/E/G ratio of 4.62 and a beta of 0.83. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.15. The company had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.05 EPS. As a group, analysts anticipate that Danaher Co. will post 7.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, July 26th. Stockholders of record on Friday, June 28th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, June 28th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.39%. Danaher’s payout ratio is currently 18.31%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on DHR shares. Stifel Nicolaus increased their price objective on Danaher from $235.00 to $250.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. Robert W. Baird increased their price objective on Danaher from $271.00 to $278.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. The Goldman Sachs Group increased their price objective on Danaher from $225.00 to $250.00 and gave the stock a “neutral” rating in a report on Wednesday, July 24th. TD Cowen increased their price objective on Danaher from $290.00 to $310.00 and gave the stock a “buy” rating in a report on Wednesday, July 24th. Finally, HSBC raised Danaher from a “hold” rating to a “buy” rating and increased their price objective for the stock from $250.00 to $280.00 in a report on Wednesday, April 17th. Six analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $276.88.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.